Глюкозамин Орион - инструкция по применению Перевести на русский язык:. Вы можете ознакомиться с инструкцией по применению препарата Варфарин на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Симдакс на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Метотрексат на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Дивигель на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Темодал на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Куплатон на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Глюкозамин на украинском или русском языках, или найти аналоги. Вы можете ознакомиться с инструкцией по применению препарата Гуарем на украинском или русском языках, или найти аналоги. N30, ORION PHARMA INTERNATIONAL Руководство для покупателей Данная информация предназначена для людей, которые приобрели Easyhaler для Devisol D3 Инструкция По Особые указания по применению: Капли могут быть введены легко с пипетки Каждая упаковка содержит подробные инструкции для … Devisol Drops D3 - витамины для детей в каплях на основе кокосового масла, хорошо усваиваются организмом. Devisol Drops D3 инструкция на русском как применять в Инструкция по применению на русском языке. Прием препарата прошел успешно, если вы почувствовали сладкий привкус во рту. На сегодня связи между терапией ….
Medicines and generics searching. Query must consist minimum of 3 characters:. Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for treating a health problem or disease, or prescribing any medication. LV is not responsible for any damage to your health as the result of self treatment. Maximum allowed state defined price from ZVA webpage Euro: PDF] document with usage instructions for a medicament from EMA web site can be downloaded here. EPAR summary for the public. This document is a summary of the European public assessment report EPAR for Procoralan. Procoralan is a medicine that contains the active substance ivabradine. It is available as tablets 5 and 7. The medicine can only be obtained with a prescription. Procoralan is taken twice a day with meals, once in the morning and once in the evening. Reproduction is authorised provided the source is acknowledged. The recommended starting dose is 5 mg twice a day, which the doctor may increase to 7. The symptoms of angina are caused by the heart not receiving enough oxygenated blood. In stable angina, these symptoms appear during physical effort. The symptoms of heart failure are caused by the heart not pumping enough blood around the body. Procoralan has been studied in five main studies involving over 4, adults with long-term stable angina. Each study lasted three to four months. Procoralan has also been compared with placebo in one main study involving 6, patients with longterm moderate to severe heart failure. The main measure of effectiveness was the time until death due to disease of the heart or blood vessels, or hospitalisation due to worsening heart failure. Another study compared Procoralan with placebo in 19, patients with coronary heart disease and without clinical heart failure. In patients with long-term stable angina, Procoralan was more effective than placebo at improving exercise capacity and was as effective as atenolol and amlodipine. In patients with long-term heart failure, Procoralan was more effective than placebo at preventing death due to disease of the heart or blood vessels or hospitalisation due to worsening heart failure: Caution is needed if Procoralan is taken with some other medicines. See the package leaflet for full details. For the treatment of angina, Procoralan was originally approved for patients whose heart rate is at least 60 beats per minute. A risk management plan has been developed to ensure that Procoralan is used as safely and effectively as possible. The European Commission granted a marketing authorisation valid throughout the European Union for Procoralan on 25 October This summary was last updated in More information can be found here. Instruction , annotation source: The European Medicines Agency. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health - [Nov]. Unreasonable use of drugs is harmful to your health! Please consult with your doctor or pharmacist. Carefully read medicine application instructions! LV RU EN DE. What is Procoralan used for? How is Procoralan used? An agency of the European Union. Query must consist minimum of 3 characters: Queues for medical examinations. Lists of compensated medicines. Please enable JavaScript to contact.
https://gist.github.com/384f822feb5b2d2138d1de8ebb4a96be
https://gist.github.com/b02bfc11580c2d00aade0c5257400557
https://gist.github.com/ec2a608a41d37fb4ce58695f0d6eb314